Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peptide Vaccine (URLC10, CDCA1, KIF20A) in Advanced NSCLC
NCT01950156Phase 2Completed
- Sponsor
- Shiga University
- Start
- Sep 2011
- Primary completion
- Mar 2019
- Modality
- Recombinant Proteins and Enzymes, Peptides, Peptide-based Cancer Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of URLC10, CDCA1 in non-small cell lung cancer (NSCLC), sponsored by Shiga University. Started Sep 2011; status: completed.
02
Drugs
URLC10CDCA1
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01950156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01950156.